August 20, 2026
Regional intelligence on Drugs, Diagnostics, Devices & Digital Health
* may need subscription to view
Big4Bio CEO Weekly - Q&A Life Sciences Leaders
BIG4BIO CEO WEEKLY Q&A:
Brian Farmer, CEO of Inipharm
In this Q&A, Farmer discusses the genetic discovery that inspired Inipharm's approach, why an oral small-molecule strategy sets the company apart from RNA-based competitors, early clinical signals behind INI-822, and what it takes to build a small team capable of advancing a novel drug target. More

Press Releases

  • Amplitude Therapeutics and Lilly: Enter Strategic Collaboration to Develop Trans-Amplifying RNA Vaccines for Infectious Diseases More
  • Charles River Laboratories and Medigen Vaccine Biologics: Collaborate to Advance New Vaccine Development Programs Through Next Generation Sequencing More
  • Ingenia Therapeutics: Nominated for Both the Prix Galien USA and the Inaugural Prix Galien Korea for Best Startup More
  • Pillar Biosciences, LC-SCRUM-Asia and LSI Medience: Liquid Biopsy Screening Collaboration in Lung Cancer More
  • Taiho Oncology and Cullinan Therapeutics: Zipalertinib Plus Chemotherapy First-Line Phase 3 REZILIENT3 Trial Data Selected for Presidential Symposium Presentation at the IASLC 2026 World Conference on Lung Cancer More

Financial News

CRCFO Advisory
Reassessing your business plan?
We provide financial leadership.
Smart. Nimble. Flexible.
Learn More  →
  • Amylyx Pharmaceuticals: Pricing of an Upsized $500 Million Underwritten Public Offering of Common Stock More
  • Big4Bio: On Your Mark Returns for JPM Week 2027, With a Live Site Alongside the Guide More
  • BioPharmCatalyst Weekly Watchlist: Key PDUFAs Left for the Quarter More
  • Replimune: Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) More

Media/Misc Coverage

Pace® Life Sciences

The CDMO That Takes You Further. Your partner for Product Development, Manufacturing, Analytical Testing, Regulatory Consulting & Operational Support.
Learn More  →
  • A ‘Renaissance for Biomedicine’: Human Brain Organoids Model Development for 5 Years More
  • Big4Bio CEO Weekly Q&A: Brian Farmer, CEO of Inipharm More
  • Biotech & Pharma Updates | August 19 More
  • Cell Therapy Company Aims to Pioneer Analytics Automation More
  • More on Moderna’s Personalized Cancer Vaccine Shows Success in Phase 3 Trial More* More* More More
  • Subscribe to LifeSci Startup for Updates on US Startups More
Cyprotex - An Evotec Company | Your trusted ADME-Tox partner. Discovery Bioanalysis. Tailored for the molecules that matter most. 1. Peptide therapeutics, 2. Endogenous biomarkers, 3. Complex small molecules. Learn more >

Career Moves

Telling Your Science Story to Investors
Learn More  →
  • Foresite Labs: Appoints Dr. Jorge Reis-Filho to Chief Strategy Officer and Operating Partner - Joins Foresite Capital as Venture Partner More
  • OPPORTUNITY: Chief Operating Officer, Remote More
  • OPPORTUNITY: Computational Scientist, New York More
  • OPPORTUNITY: Head of Computational Method Development, Boston More
  • Slone Partners: Fractional Leadership in Biotech and Life Sciences - When it Works and Why More
  • Slone Partners: Places Farhad Ghavami as Chief Executive Officer at SeqCenter More

Events

Note: Events may be in any Big4Bio region or virtual
Spotlight Event: BioFuture Oct 27-28
Learn More  →

SEE FULL EVENT SCHEDULE AT THE BIOCALENDAR

Companies

DISCOVER COMPANIES
Big4Bio: Boston Life Science Company Directory
Locate a specific company or explore new companies in life science.
Explore our Company Directory Provided courtesy of
BioPharmGuy Logo

Boston Sponsors


Follow us

Spotlights       Get Featured       Company Directory      News       Contact       Subscribe

You are receiving this email because you signed up for one of our newsletters at Big4Bio.com, signed up at one of our partner or sponsor events, or given as a gift subscription by your firm or organization. Unsubscribe

Big4Bio:Boston, all rights reserved 2026

© 2026 Big4Bio, a division of BigBio Communications. All rights reserved.